Risks for childhood leukemia

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. Childhood cancers are rare and there is less known about the risks. Most childhood risks are not modifiable. This means that you can't change them. Until we learn more about the risks for childhood leukemia, there are no specific ways to lower the risk.

About 75% of all childhood leukemias are acute lymphoblastic leukemia (ALL). ALL develops more often in boys and usually occurs in children between the ages of 1 and 4 years. About 20% of all childhood leukemias are acute myeloid leukemia (AML). Childhood AML is more common in children before the age of 2 and in teenagers.

Some children with certain genetic conditions have a higher than average risk for childhood leukemia. Talk to your doctor about your child's risk.

The following can increase the risk for childhood leukemia.

Genetic syndromes

Genetic syndromes are diseases or disorders caused by a change (mutation) in one or more genes. The following genetic syndromes can increase the risk of developing childhood leukemia.

Down syndrome is a chromosome disorder caused by an extra chromosome 21. It is linked with intellectual disability and a characteristic facial appearance. Children with Down syndrome have a higher risk of developing several medical conditions, including childhood leukemia.

Bloom syndrome is an inherited condition caused by mutations in a certain chromosome. Signs include shorter than average height, a high-pitched voice and a characteristic facial appearance. Bloom syndrome is associated with an increased risk of developing cancer, including leukemia, lymphoma, breast, cervical, colon, stomach, laryngeal and non-melanoma skin cancers, as well as Wilms tumour. People with Bloom syndrome often develop several different types of cancer.

Fanconi anemia is an inherited condition that affects the bone marrow so it cannot make red blood cells, white blood cells or platelets. Fanconi anemia increases the risk of AML, myelodysplastic syndromes, and oral and oropharyngeal cancers.

Ataxia-telangiectasia is an inherited disease that affects the nervous system, immune system and other body systems. Signs and symptoms include loss of balance, poor coordination, frequent infections, red eyes (due to widening of blood vessels) and abnormal eye movements. Ataxia-telangiectasia is associated with an increased risk of developing some cancers, including leukemia and lymphoma.

Neurofibromatosis type 1 is an inherited condition that affects the nervous system. It affects the development and growth of neurons (nerve cells), causes tumours (neurofibromas) to grow on nerves and may produce other abnormalities in muscles, bones and skin. Sometimes cancerous tumours called malignant peripheral nerve sheath tumours may grow along the nerves. Neurofibromatosis type 1 increases the risk of leukemia, neuroendocrine tumours, soft tissue sarcoma, brain tumours and neuroblastoma.

Wiskott-Aldrich syndrome is an inherited condition that affects the blood cells and the cells of the immune system. It usually only affects boys. Wiskott-Aldrich syndrome increases the risk of developing AML, Hodgkin lymphoma and non-Hodgkin lymphoma.

Li-Fraumeni syndrome is an inherited condition that is associated with an increased risk of developing certain types of cancers, including acute leukemia, breast cancer, brain tumours, soft tissue and bone sarcomas and adrenal cortical carcinomas. People with Li-Fraumeni syndrome tend to develop several different types of cancer before the age of 45.

Shwachman-Diamond syndrome is an inherited condition that affects the bone marrow, pancreas and bones. Shwachman-Diamond syndrome increases the risk of AML and myelodysplastic syndromes.

Having a sibling with leukemia

Children who have a brother or sister with leukemia have a slightly higher risk of developing leukemia than children in the general population. In identical twins, this risk is much higher, especially if leukemia develops in the first year of life.

Radiation

Children exposed to high doses of radiation from nuclear reactor accidents have a higher risk of developing leukemia. Most leukemias that develop after exposure to radiation are AML but they can also be ALL.

Children who had radiation therapy to treat cancer or another health condition have a higher risk of then developing leukemia. This risk is usually outweighed by the benefit of treating the original cancer.

Most leukemias that occur after radiation therapy are AML rather than ALL. The risk of developing AML is greater if both chemotherapy and radiation were used in treatment.

Previous chemotherapy

Children who had certain types of chemotherapy have a higher risk for leukemia. Most leukemias that occur after previous chemotherapy are AML rather than ALL. The leukemia usually develops within 5 years after treatment. This risk is usually outweighed by the benefit of treating the original cancer.

High birth weight

A birth weight greater than 4,000 g (8.9 pounds) increases the risk for ALL.

Possible risks

Exposure to the following have been linked with childhood leukemia, but more research is needed to know for sure that they are risks. The exposure studied could be exposure during childhood, in utero (before being born) or to sperm or egg before they join at conception.

  • low levels of radiation in utero and in early childhood
  • electromagnetic fields (EMFs) in childhood
  • certain pesticides in utero or as a child
  • either parent smoking tobacco (before conception) or in pregnancy
  • second-hand smoke in childhood
  • alcohol in utero
  • benzene in utero, in childhood or through either parent's exposure before conception
  • chemicals in paint (before conception or in utero)

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • Amigou A, Sermage-Faure C, Orsi L, Leverger G, Baruchel A, et al . Road traffic and childhood leukemia: the ESCALE study (SFCE). Environmental Health Perspectives.
  • Gramatges MM, O'Brien MM, Rabin KR. Acute lymphoblastic leukemia. Pizzo PA, Poplack DG, eds.. Principles and Practice of Pediatric Oncology . 8th ed. Philadelphia, PA: Wolters Kluwer; 2021: 16:1592-1732.
  • Aplenc R, Elgarten CW, Choi JK, Meshinchi S. Acute myeloid leukemia and myelodysplastic syndromes. Pizzo PA, Poplack DG, eds.. Principles and Practice of Pediatric Oncology . 8th ed. Philadelphia, PA: Wolters Kluwer; 2021: 17:1733-1897.
  • Roman E, Lightfoot T, Picton S, Kinsey S. Childhood cancers. Thun MJ, Linet MS, Cerhan JR, Haiman CA Schottenfeld D, eds.. Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: 59.
  • Bassil KL, Vakil C, Sanborn M, et al . Cancer health effects of pesticides . Canadian Family Physician . Mississauga, ON : The Family Physicians of Canada ; 2007 : 53(10):1704-1711 .
  • Belson, M. et al . Risk factors for acute leukemia in children: a review. Environmental Health Perspectives. Seattle: Fred Hutchinson Cancer Research Center; 2007.
  • Belson, M. et al . Risk factors for acute leukemia in children: a review. Environmental Health Perspectives. Seattle: Fred Hutchinson Cancer Research Center; 2007.
  • Carlos-Wallace FM, Zhang L, Smith MT, Rader G, Steinmaus C . Parental, in utero, and early-life exposure to benzene and the risk of childhood leukemia: a meta-analysis. American Journal of Epidemiology. 2016: http://www.medscape.com/viewarticle/857205_1.
  • Carozza SE, Li B, Elgethun K, et al . Risk of childhood cancers associated with residence in agriculturally intense areas in the United States. Environmental Health Perspectives. Triangle Park, NC: National Institute of Environmental Health Sciences; 2008.
  • Chokkalingam AP, Metayer C, Scelo G, Chang JS, Schiffman J, et al . Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia. Cancer Causes and Control. 2012.
  • Crump C, Sundquist J, Sieh W, Winkleby MA, Sundquist K . Perinatal and familial risk factors for acute lymphoblastic leukemia in a Swedish national cohort. Cancer. 2015.
  • Evrard, A.S. and Hemon, D . Ecological association between indoor radon concentration and childhood leukemia in France, 1990-1998. European Journal of Cancer Prevention. Lippincott, Williams & Wilkins; 2005.
  • Houot J, Marquant F, Goujon S, Faure L, Honore C, Roth MH et al . Residential proximity to heavy traffic roads, benzene exposure, and childhood leukemia - the GEOCAP study, 2002-2007. American Journal of Epidemiology. 2015.
  • Infant-Rivard C, Weichental S . Pesticides and childhood cancer: an update of Zahm and Ward's 1998 review. Journal of Toxicology and Environmental Health Part B: Critical Reviews. Taylor & Francis, Inc; 2007.
  • Infante-Rivard, C. et al . Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. British Journal of Cancer (BJC). Hampshire: Nature Publishing Group; 2000.
  • International Agency for Research on Cancer (IARC). Volume 83: Tobacco Smoke and Involuntary Smoking. 2004: boolean: yes.
  • International Agency for Research on Cancer (IARC). Volume 44: Alcohol Drinking. 1988: http://monographs.iarc.fr/ENG/Monographs/vol44/mono44.pdf.
  • International Agency for Research on Cancer (IARC). Volume 80: Non-ionizing Radiation Part 1: Static and Extremely Low Frequency (ELF) Electric and Magnetic Fields. 2002: http://monographs.iarc.fr/ENG/Monographs/vol80/mono80.pdf.
  • International Agency for Research on Cancer (IARC). Volume 75: Ionizing Radiation Part 1: X- and Gamma (y)-Radiation, and Neutrons. 2000: http://monographs.iarc.fr/ENG/Monographs/vol75/mono75.pdf.
  • International Agency for Research on Cancer (IARC). Volume 98: Painting, Firefighting and Shiftwork. 2010: http://monographs.iarc.fr/ENG/Monographs/vol98/mono98.pdf.
  • International Agency for Research on Cancer (IARC). Volume 96: Alcohol Consumption and Ethyl Carbamate. 2010: http://monographs.iarc.fr/ENG/Monographs/vol96/mono96.pdf.
  • International Agency for Research on Cancer (IARC). Volume 100E: Personal Habits and Indoor Combustions. 2012: http://monographs.iarc.fr/ENG/Monographs/vol100E/mono100E.pdf.
  • Kaletlch, U. et al . Childhood cancer and residential radon exposure – results of a population-based case-control study in Lower Saxony (Germany). Radiation and Environmental Biophysics. Springer; 1999: http://www.springer.com/physics/biophysics/journal/411.
  • Lee KM, Ward MH, Han S, et al . Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leukemia Research. Elsevier; 2009.
  • Lubin, J.H. et al . Case–control study of childhood acute lymphoblastic leukemia and residential radon exposure. Journal of the National Cancer Institute. Cary, NC: Oxford University Press; 1998.
  • Ma, X. et al . Critical windows of exposure to household pesticides and risk of childhood leukemia. Environmental Health Perspectives. Triangle Park, NC: National Institute of Environmental Health Sciences; 2002.
  • Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, et al . Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013.
  • McNally, R.J.Q. and Eden, T.O.B . An infection aetiology for childhood acute leukemia: a review of the evidence. British Journal of Haematology. Oxford, UK: Blackwell Publishing, Inc; 2004.
  • Metayer C, Buffler PA . Residential exposures to pesticides and childhood leukemia. Radiation Protection Dosimetry. Oxford University Press; 2008.
  • Milne E, Greenop KR, Metayer C, Schuz J, Petridou E, et al . Fetal growth and childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium. International Journal of Cancer. 2013.
  • O'Neill KA, Murphy MF, Bunch KJ, Puumala SE, Carozza SE, et al . Infant birthweight and risk of childhood cancer: international population-based case control studies of 40000 cases. International Journal of Epidemiology. 2015.
  • Paltiel O, Tikellis G, Linet M, Golding J, Lemeshow S, et al . Birthweight and childhood cancer: preliminary findings from the International Childhood Cancer Cohort Consortium (14C). Paediatric and Perinatal Epidemiology. 2015.
  • Pearce, M. S. et al . Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. Elsevier; 2012.
  • Petridou, E. et al . Leukemias. Adami, H.-O., Hunter, D., & Trichopoulos, D. Textbook of Cancer Epidemiology. 2nd ed. Oxford: Oxford University Press; 2008: 28: 694-710.
  • Raaschou-Nielsen, O., Andersen, C. E., Andersen, H. P., et al . Domestic radon and childhood cancer in Denmark. Epidemiology. Baltimore, MD: Lippincott Williams & Wilkins; 2008.
  • Raashoi-Nielson O . Indoor radon and childhood leukemia. Radiation Protection Dosimetry. Oxford University Press; 2008.
  • Rajaraman, P. et al . Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study. British Medical Journal (BMJ). BMJ Publishing Group Ltd; 2011.
  • Ross, J.A. & Spector, L.G . Cancers in children. Schottenfeld, D. & Fraumeni, J. F. Jr. (Eds.). Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 2006: 65: 1252-1268.
  • Rudant J, Menegaux F, Levergeret G, et al . Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE Study (SFCE). Environmental Health Perspectives. Triangle Park, NC: National Institute of Environmental Health Sciences; 2007.
  • Secretan S, Straif K, Baan R, et al . A review of human carcinogens: Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncology. Elsevier; 2009.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society